Hims & Hers Health has entered into a definitive agreement to acquire Eucalyptus, a digital health platform with established operations across Australia, the United Kingdom, and Germany, in a transaction valued at up to $1.15 billion. The acquisition is structured to close by mid-2026 and represents a significant step in the telehealth provider's strategy to establish a substantive international presence beyond its core U.S. market.
The Eucalyptus acquisition provides Hims & Hers with immediate operational footprint in three developed healthcare markets while positioning the company for subsequent expansion into additional regions including Japan and Canada. By integrating Eucalyptus's existing infrastructure and regulatory relationships, Hims & Hers aims to accelerate market entry timelines and leverage established patient bases in territories where digital health adoption has gained meaningful traction.
The transaction underscores the continued consolidation trend within the digital health sector as larger platforms pursue geographic diversification to drive growth. For Hims & Hers, the acquisition addresses the company's previous reliance on U.S. operations and signals management's commitment to building a globally distributed revenue model amid evolving competitive and regulatory dynamics in domestic markets.